Patents by Inventor Joanne Craig

Joanne Craig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicaments
    Patent number: 5705520
    Abstract: The present invention, relates to 3-?2-(dimethylamino)ethyl!-N-methyl-1H-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof, and to pharmaceutical compositions containing same. The compound is useful in the treatment of conditions associated with cephalic pain, in particular migraine. The pharmaceutical compositions are particularly useful as intranasal formulations.
    Type: Grant
    Filed: May 21, 1996
    Date of Patent: January 6, 1998
    Assignee: Glaxo Group Limited
    Inventors: Joanne Craig, Derek Leslie Crookes, Stephen John Skittrall
  • Medicaments
    Patent number: 5554639
    Abstract: 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof are disclosed. The compound is of use in the preparation of pharmaceutical compositions, particularly for intranasal formulations, for use in the treatment of conditions associated with cephalic pain, in particular migraine.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: September 10, 1996
    Assignee: Glaxo Group Limited
    Inventors: Joanne Craig, Derek L. Crookes, Stephen J. Skittrall
  • Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide
    Patent number: 5393773
    Abstract: A method of treating a human suffering from or susceptable to cephalic pain by intramasally administering 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indol-5-methanesulphonamide in a pH range of from 9-11.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: February 28, 1995
    Assignee: Glaxo Group Limited
    Inventors: Joanne Craig, David A. Saynor